United Health Products (UEEC) 10-Q2019 Q3 Quarterly report

Filed: 1 Nov 19, 4:06pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Adam, adverse, advice, animal, artificially, bone, chronic, Clinical, Colberg, confirming, consented, deceptive, defamation, defamatory, Diamond, distort, effort, enable, false, Gefvert, higher, illegitimate, illicit, inherent, injure, integrated, issuable, Item, leader, libel, manipulation, model, orthopedic, pathology, patient, position, preclinical, published, reduced, rescheduled, scale, scheme, short, Sonya, spending, suitability, Surgicel, swine, target, turn, unlawful, visit, Western, White

Removed: abroad, acronym, Administration, affix, aim, announced, approve, Area, behavioral, billion, biomedical, CE, clear, committee, component, conduct, Conformit, consumer, CtQ, designated, device, Dick, documentation, drug, EEA, ensuring, environmental, Europe, European, exceeding, expect, expected, extensive, Field, finalizing, focused, food, formally, French, full, GDP, healthy, herbal, independently, intended, investigator, involving, IRB, kit, Korea, label, leading, making, manufacturer, mark, marking, met, Ministry, nationwide, NYSE, observe, obtained, obtaining, participating, partner, people, population, program, promote, prospective, protect, protocol, purpose, Quantum, recruited, regulatory, relevant, request, requiring, resolution, reviewed, safeguard, scheduled, selected, serve, site, Society, South, Sporting, stage, step, Stream, team, threatened, trillion, Union, vision, welfare

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

UEEC similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350), Nate Knight, Principal Financial Officer of United Health Products, Inc. (the "Company") of the Company, hereby certifies that, to the best of his knowledge:

	1.	The Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, to which this Certification is attached as Exhibit 32.2 (the "Quarterly Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

	2.	The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

In witness whereof, the undersigned have set their hands hereto as of the November 1, 2019.


	By:	/s/ Nate Knight
		Nate Knight
		Principal Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.